Lithium Citrate

Applications

NDAs, BLAs and generic ANDAs for this ingredient, oldest first; each opens its full history

Approved	Application	Sponsor	Supplements	Marketing
Dec 23, 1980	Lithium CitrateNDA 18421 · New formulation or manufacturer	Hikma	26	Discontinued
May 21, 1986	Lithium CitrateANDA 70755	Pai Holdings Pharm	13	Marketed
Aug 14, 2023	Lithium CitrateANDA 218036	Rubicon Research	0	Marketed
Mar 18, 2024	Lithium CitrateANDA 217183	Sciegen Pharms	0	Marketed
—	LithonateNDA 17672	Solvay	0	Discontinued

Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA